Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1911389 | 0.85 | OR51E2 (0.46) | GAAOR51E2HTTMEN1KMT2A | |
| SCHEMBL2203559 | 0.81 | ALDH1A1 (0.56) | GAAOR51E2RAB9AHTTCA12 | |
| SCHEMBL14216549 | 0.81 | GAA (0.53) | GAARAB9AADRA2AADRA2CADRA1D | |
| SCHEMBL5223370 | 0.80 | ERN1 (0.56) | OR51E2RAB9AHTTALDH1A1MAPT | |
| SCHEMBL31432473 | 0.80 | TRIM24 (0.56) | GAAOR51E2RAB9AADRA1AMEN1 | |
| SCHEMBL2095308 | 0.80 | OR51E2 (0.48) | GAAOR51E2RAB9AHTTMEN1 | |
| SCHEMBL9947244 | 0.79 | OR51E2 (0.50) | OR51E2ADRA1AHTTKMT2AALDH1A1 | |
| SCHEMBL1758614 | 0.78 | ALDH1A1 (0.56) | GAAOR51E2RAB9AHTTCA12 | |
| SCHEMBL19390278 | 0.77 | GAA (0.49) | GAARAB9AADRA2AADRA2CADRA1D | |
| SCHEMBL1188765 | 0.76 | OR51E2 (0.45) | GAAOR51E2RAB9AHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7211202-B2 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ATOFINA (FR) | 2007-05-01 | — | — | US | claimed |
| EP-1428857-B1 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ARKEMA FRANCE (FR) | 2007-01-31 | — | — | EP | claimed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| CN-119751280-A | Preparation method of 2-methyl-4-methoxy diphenylamine | 河北建新化工股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-11111252-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) | 2021-09-07 | — | — | US | disclosed |
| US-11001595-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) | 2021-05-11 | — | — | US | disclosed |
| US-20200369681-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | 2020-11-26 | — | — | US | disclosed |
| US-20200369680-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-11-26 | — | — | US | disclosed |
| US-10774090-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) | 2020-09-15 | — | — | US | disclosed |
| US-20190233432-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-08-01 | — | — | US | disclosed |
| WO-1998032805-A1 | COATING COMPOSITION, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN ANTICORROSIVE PAINT | DSM N.V. (NL) | 1998-07-30 | — | — | WO | disclosed |
| WO-1998031754-A1 | RADIATION CURABLE CONDUCTIVE COATING DISPERSION, PROCESS FOR ITS PREPARATION AND COATINGS MADE OF IT | DSM N.V. (NL) | 1998-07-23 | — | — | WO | disclosed |
| EP-0821040-A1 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0821041-A2 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0538939-B1 | Polymer composition | DSM NV (NL) | 1996-06-19 | — | — | EP | disclosed |
| EP-0589529-A1 | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1994-03-30 | — | — | EP | disclosed |
| US-5262483-A | Styrene-maleic anhydride and polyaniline grafted with processability and conductivity | DSM N.V. (NL) | 1993-11-16 | — | — | US | disclosed |
| EP-0538939-A1 | Polymer composition | DSM N.V. (NL) | 1993-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369680-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | DPYD, HPRT1, TPMT | GAA 3776/4885OR51E2 3727/4885RAB9A 1463/4885 |
| US-20200369681-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | DPYD, TYMP, TPMT | GAA 2163/4885OR51E2 4362/4885RAB9A 2270/4885 |
| US-20190233432-A1 | PYRIMIDINE COMPOUNDS AND PYRIMIDO INDOLE COMPOUNDS AND METHODS OF USE | DPYD, HPRT1, TPMT | GAA 3763/4885OR51E2 3729/4885RAB9A 1420/4885 |
| US-10774090-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DPYD, HPRT1, TPMT | GAA 3763/4885OR51E2 3729/4885RAB9A 1420/4885 |
| US-11111252-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DPYD, TYMP, TPMT | GAA 2163/4885OR51E2 4362/4885RAB9A 2270/4885 |
| US-11001595-B2 | Pyrimidine compounds and pyrimido indole compounds and methods of use | DPYD, HPRT1, TPMT | GAA 3776/4885OR51E2 3727/4885RAB9A 1463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.